| | Editorial Foreword Ther Clin Risk Manag. 2007 August; 3(4): 505–506. Published online 2007 August. PMCID: PMC2374930 Reviews Current treatment options in the management of chronic prostatitis Alain Jean Duclos, Chun-Te Lee, and Daniel Arthur Shoskes PMCID: PMC2374945 Drug forecast – the peptide deformylase inhibitors as antibacterial agents David R P Guay PMCID: PMC2374925 A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaire Mohamed Arafa and Rany Shamloul PMCID: PMC2374931 Role of posaconazole in the management of oropharyngeal and esophageal candidiasis Jose A Vazquez PMCID: PMC2374940 Review of thalidomide in the treatment of newly diagnosed multiple myeloma Federica Cavallo, Mario Boccadoro, and Antonio Palumbo PMCID: PMC2374936 Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes Aristoteles A N Giagounidis, Ulrich Germing, Sabine Haase, and Carlo Aul PMCID: PMC2374932 Reflections on adjuvant treatment of gastric cancer Albert Abad, José Luis Manzano, and Cristina Martí PMCID: PMC2374927 Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results Marco Metra, Savina Nodari, Tania Bordonali, Patrizia Milani, Carlo Lombardi, Silvia Bugatti, Benedetta Fontanella, Giulia Verzura, Rossella Danesi, and Livio Dei Cas PMCID: PMC2374926 The renaissance of fixed dose combinations: Combivir Simon D Portsmouth and Christopher J Scott PMCID: PMC2374941 Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol Domenico De Berardis, Nicola Serroni, Rosa Maria Salerno, and Filippo Maria Ferro PMCID: PMC2374943 Clinical studies with oral lipid based formulations of poorly soluble compounds Dimitrios G Fatouros, Ditte M Karpf, Flemming S Nielsen, and Anette Mullertz PMCID: PMC2374933 Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection Hee Bok Chae and Hie-Won Hann PMCID: PMC2374938 A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma Gennaro D’Amato, Antonello Salzillo, Amedeo Piccolo, Maria D’Amato, and Gennaro Liccardi PMCID: PMC2374942 A review of the use of adapalene for the treatment of acne vulgaris Suleyman Piskin and Erol Uzunali PMCID: PMC2374937 Using risk management files to identify and address causative factors associated with adverse events in pediatrics Paul D Hain, James W Pichert, Gerald B Hickson, Sandra H Bledsoe, David Hamming, Jacob Hathaway, and Carolyn Nguyen PMCID: PMC2374929 Prevention of shingles: safety and efficacy of live zoster vaccine Dianna Quan, Randall J Cohrs, Ravi Mahalingam, and Donald H Gilden PMCID: PMC2374947 Review of tipranavir in the treatment of drug-resistant HIV Hendrik Streeck and Jürgen Kurt Rockstroh PMCID: PMC2374948 A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD) Evangelos Kalaitzakis and Einar Björnsson PMCID: PMC2374928 A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer Michael H Nelson and Christian R Dolder PMCID: PMC2374939 Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin David M Bamberger PMCID: PMC2374935 Original Research How should we measure medication adherence in clinical trials and practice? Jeannie K Lee, Karen A Grace, Terri G Foster, Monica J Crawley, Goldina I Erowele, Hazel J Sun, Phuong T Turner, Lance E Sullenberger, and Allen J Taylor PMCID: PMC2374934 Ondansetron oral disintegrating tablets for the prevention of postoperative vomiting in children undergoing strabismus surgery Deborah S Wagner, Virginia Gauger, Devi Chiravuri, and Kristin Faust PMCID: PMC2374946 Evaluation of patient care interventions and recommendations by a transitional care pharmacist K Bruce Bayley, Lucy A Savitz, Teresa Maddalone, Stephen E Stoner, Jacquelyn S Hunt, and Robert Wells PMCID: PMC2374944 |
